Print

Endocyte, Inc. (ECYT) to Present at Upcoming Healthcare Conferences  
11/7/2012 9:36:37 AM

WEST LAFAYETTE, Ind., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy in cancer and other serious diseases, today announced that management will present at the following upcoming conferences: